156 related articles for article (PubMed ID: 30334297)
41. Tumour multifocality and grade predict intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma without a history of bladder cancer.
Narukawa T; Hara T; Arai E; Komiyama M; Kawahara T; Kanai Y; Fujimoto H
Jpn J Clin Oncol; 2015 May; 45(5):488-93. PubMed ID: 25681388
[TBL] [Abstract][Full Text] [Related]
42. Ubiquilin2 as a novel marker for detection of urothelial carcinoma cells in urine.
Shimada K; Fujii T; Tatsumi Y; Anai S; Fujimoto K; Konishi N
Diagn Cytopathol; 2016 Jan; 44(1):3-9. PubMed ID: 26303000
[TBL] [Abstract][Full Text] [Related]
43. Intravesical recurrence after surgical management of urothelial carcinoma of the upper urinary tract.
Hirano D; Okada Y; Nagane Y; Satoh K; Mochida J; Yamanaka Y; Hirakata H; Yamaguchi K; Kawata N; Takahashi S; Henmi A
Urol Int; 2012; 89(1):71-7. PubMed ID: 22677699
[TBL] [Abstract][Full Text] [Related]
44. Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial Carcinoma.
Oikawa M; Hatakeyama S; Yoneyma T; Tobisawa Y; Narita T; Yamamoto H; Hashimoto Y; Koie T; Narita S; Sasaki A; Tsuchiya N; Habuchi T; Takahashi I; Nakaji S; Ohyama C
Eur Urol Focus; 2018 Apr; 4(3):405-411. PubMed ID: 28753809
[TBL] [Abstract][Full Text] [Related]
45. The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
Kishimoto N; Takao T; Kuribayashi S; Yamamichi G; Nakano K; Kawamura M; Tsutahara K; Tanigawa G; Yamaguchi S
Int J Clin Oncol; 2017 Feb; 22(1):153-158. PubMed ID: 27614622
[TBL] [Abstract][Full Text] [Related]
46. Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinoma.
Gohji K; Fujimoto N; Komiyama T; Fujii A; Ohkawa J; Kamidono S; Nakajima M
Cancer; 1996 Dec; 78(11):2379-87. PubMed ID: 8941010
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
48. Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study.
Guo RQ; Xiong GY; Yang KW; Zhang L; He SM; Gong YQ; He Q; Li XY; Wang ZC; Bao ZQ; Li XS; Zhang K; Zhou LQ
Urol Oncol; 2018 Jul; 36(7):342.e15-342.e23. PubMed ID: 29706459
[TBL] [Abstract][Full Text] [Related]
49. Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma.
Jou YC; Tsai YS; Hsieh HY; Chen SY; Tsai HT; Chen KJ; Wang ST; Shiau AL; Wu CL; Tzai TS
Urol Oncol; 2013 Nov; 31(8):1806-11. PubMed ID: 22609059
[TBL] [Abstract][Full Text] [Related]
50. Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations.
Sánchez-Infantes D; Gallego-Escuredo JM; Díaz M; Aragonés G; Sebastiani G; López-Bermejo A; de Zegher F; Domingo P; Villarroya F; Ibáñez L
Int J Obes (Lond); 2015 May; 39(5):742-6. PubMed ID: 25599612
[TBL] [Abstract][Full Text] [Related]
51. Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa.
Dostálová I; Kaválková P; Haluzíková D; Lacinová Z; Mráz M; Papezová H; Haluzík M
J Clin Endocrinol Metab; 2008 Sep; 93(9):3627-32. PubMed ID: 18559909
[TBL] [Abstract][Full Text] [Related]
52. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma.
Zhang XK; Zhang ZL; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y
Jpn J Clin Oncol; 2015 Nov; 45(11):1069-75. PubMed ID: 26355163
[TBL] [Abstract][Full Text] [Related]
53. Ureteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
Hu CY; Tsai YC; Wang SM; Huang CY; Tai HC; Chen CH; Pu YS; Lin WC; Huang KH
Biomed Res Int; 2015; 2015():527976. PubMed ID: 25874217
[TBL] [Abstract][Full Text] [Related]
54. The De Ritis (aspartate transaminase/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinoma.
Cho YH; Hwang JE; Chung HS; Kim MS; Hwang EC; Jung SI; Kang TW; Kwon DD; Choi SH; Kim HT; Kim TH; Kwon TG; Noh JH; Kim MK; Kim CS; Kang SG; Kang SH; Cheon J; Lee CH; Ku JY; Ha HK; Tae BS; Jeong CW; Ku JH; Kwak C; Kim HH
Int Urol Nephrol; 2017 Aug; 49(8):1383-1390. PubMed ID: 28484945
[TBL] [Abstract][Full Text] [Related]
55. [Management of the bladder cuff removal by open excision versus transurethral resection of the ureteral orifice after laparoscopic radical nephroureterectomy in upper urinary tract--urothelial carcinoma].
Tibi B; Quintens H; Carpentier X; Albano L; Durand M; Amiel J
Prog Urol; 2014 Feb; 24(2):94-101. PubMed ID: 24485078
[TBL] [Abstract][Full Text] [Related]
56. Upper urinary tract urothelial carcinoma in eastern Taiwan: high proportion among all urothelial carcinomas and correlation with chronic kidney disease.
Chen CY; Liao YM; Tsai WM; Kuo HC
J Formos Med Assoc; 2007 Dec; 106(12):992-8. PubMed ID: 18194904
[TBL] [Abstract][Full Text] [Related]
57. [Value of CK20 immunocytochemistry as an adjuvant to urine liquid-based cytology in detection of urothelial carcinoma].
Li M; Li HX; Guo HQ; Zhao H; Zhao LL; Ma JH; Li CL; Cao J; Pan QJ
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):669-73. PubMed ID: 23159079
[TBL] [Abstract][Full Text] [Related]
58. Delayed ureterectomy after incomplete nephroureterectomy for upper tract urothelial carcinoma: pathologic findings and outcomes.
Abel EJ; Fisher MB; Matin SF; Kamat AM; Dinney CP; Grossman HB
Int Braz J Urol; 2013; 39(6):817-22. PubMed ID: 24456786
[TBL] [Abstract][Full Text] [Related]
59. Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival.
Colin P; Ouzzane A; Yates DR; Audenet F; Pignot G; Arvin-Berod A; Merigot de Treigny O; Laurent G; Valeri A; Irani J; Saint F; Gardic S; Gres P; Rozet F; Neuzillet Y; Ruffion A; Rouprêt M
Ann Surg Oncol; 2012 Oct; 19(11):3613-20. PubMed ID: 22843187
[TBL] [Abstract][Full Text] [Related]
60. TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR.
Wang K; Liu T; Ge N; Liu L; Yuan X; Liu J; Kong F; Wang C; Ren H; Yan K; Hu S; Xu Z; Björkholm M; Fan Y; Zhao S; Liu C; Xu D
Oncotarget; 2014 Dec; 5(23):12428-39. PubMed ID: 25474136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
